Anticancer agent 352
Anticancer agent 352 is a heterobifunctional anticancer compound. Anticancer agent 352 exhibits only weak antiproliferative activity against both ERα-overexpressing and non-overexpressing T-Rex 293 cells induced by Doxorubicin (HY-15142A). Anticancer agent 352 can be used in breast cancer-related research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3099599-58-0
- 화학식: C51H54N10O3S
- 분자량:887.10
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
ERα |
Anticancer agent 352 (III-224) exhibits moderate antiproliferative activity against MCF7 cells (GI50 = 0.05-0.5 μM)[1].
Anticancer agent 352 exhibits only weak antiproliferative activity against both ERα-overexpressing and non-overexpressing T-Rex 293 cells induced by Doxorubicin (HY-15142A) (GI50 > 2.5 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3099599-58-0
-
분자량 887.10
-
화학식 C51H54N10O3S
-
SMILES
CC1=C(C)SC2=C1C(C3=CC=C(N4CCC(O)(CC4)CN5CCN(C6=CC=C([C@H]7C8=CC=C(O)C=C8CC[C@H]7C9=CC=CC=C9)N=N6)CC5)C=C3)=N[C@H](CC%10=NC=CO%10)C%11=NN=C(C)N2%11
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)